Antibody Isotype

Antibody Isotype designates the class of immunoglobulin defined by the constant region structure of the heavy chains, including IgG, IgA, IgM, IgE, and IgD, each conferring distinct effector functions, distribution patterns, and half-lives through specific interactions with Fc receptors, complement, and transcytosis machinery.

The biopharmaceutical industry selects antibody isotypes based on desired therapeutic mechanisms. IgG1 dominates therapeutic applications due to its long half-life, strong Fc receptor binding mediating effector functions, and established manufacturing. IgG4 offers reduced effector activity for applications requiring blocking without immune activation. IgA antibodies are explored for mucosal immunity applications. Bispecific formats sometimes combine components from different isotypes. Fc engineering within isotype classes modifies specific effector functions without changing isotype class. Immunogenicity assessment considers whether patients may develop anti-isotype responses. Understanding isotype properties guides therapeutic antibody design decisions, balancing desired effector mechanisms against potential safety considerations throughout biologic development programmes.